Stocks
Emergent BioSolutions Inc.EBS
NYSEHealthcareBiotechnology$8.07-0.68%
A developer and manufacturer of vaccines and antibody-based therapies focused on public health threats, including biodefense and infectious diseases. Its products and contract manufacturing services support government stockpiles and preparedness programs, with significant revenue tied to U.S. federa...
Market Cap: $423.8M52W Range: $4.02 – $14.06
This page tracks all publicly disclosed congressional trades in Emergent BioSolutions Inc. (EBS), a company in the Healthcare sector. 3 members of Congress have disclosed trades in this stock, including 7 purchases and 6 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
13
Unique Politicians
3
Buys
7
Sells
6
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-12-11 | STEVE COHEN | sell | $1K – $15K |
| 2021-11-05 | Josh Gottheimer | sell | $1K – $15K |